2021Iscience24 (12) : 103469
Fluvastatin mitigates SARS-CoV-2 infection in human lung cells
Zapatero-Belinchón F, Moeller R, Lasswitz L, van Ham M, Becker M, Brogden G, Rosendal E, Bi W, Carriquí-Madroñal B, Islam K, Lenman A, Gunesch A, Kirui J, Pietschmann T, Överby A, Jänsch L, Gerold G
2021Plos One16 (8) : e0255335
Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease
Ricke-Hoch M, Stelling E, Lasswitz L, Gunesch A, Kasten M, Zapatero-Belinchón F, Brogden G, Gerold G, Pietschmann T, Montiel V, Balligand J, Facciotti F, Hirsch E, Gausepohl T, Elbahesh H, Rimmelzwaan G, Höfer A, Kühnel M, Jonigk D, Eigendorf J, Tegtbur U, Mink L, Scherr M, Illig T, Schambach A, Pfeffer T, Hilfiker A, Haverich A, Hilfiker-Kleiner D
2011Molecular Biotechnology47 (3) : 262-9
Comparative analysis of transduced primary human dendritic cells generated by the use of three different lentiviral vector systems
Grabski E, Waibler Z, Schüle S, Kloke B, Sender L, Panitz S, Cichutek K, Schweizer M, Kalinke U
2021Nature595 (7868) : 596-599
A condensate-hardening drug blocks RSV replication in vivo
Risso-Ballester J, Galloux M, Cao J, Le Goffic R, Hontonnou F, Jobart-Malfait A, Desquesnes A, Sake S, Haid S, Du M, Zhang X, Zhang H, Wang Z, Rincheval V, Zhang Y, Pietschmann T, Eléouët J, Rameix-Welti M, Altmeyer R
2011Virulence2 (4) : 367-70
Host strategies against virus entry via the olfactory system
Kalinke U, Bechmann I, Detje C
2012Immunology and Cell Biology90 (5) : 505-9
Endogenous, or therapeutically induced, type I interferon responses differentially modulate Th1/Th17-mediated autoimmunity in the CNS
Kalinke U, Prinz M
2021Journal of Virology95 (10) : e00245-21
Initial HCV infection of adult hepatocytes triggers a temporally structured transcriptional program containing diverse pro- and anti-viral elements
Tegtmeyer B, Vieyres G, Todt D, Lauber C, Ginkel C, Engelmann M, Herrmann M, Pfaller C, Vondran F, Broering R, Vafadarnejad E, Saliba A, Puff C, Baumgärtner W, Miskey C, Ivics Z, Steinmann E, Pietschmann T, Brown R
2014Nature Medicine20 (1) : 47-53
Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection
Liehl P, Zuzarte-Luís V, Chan J, Zillinger T, Baptista F, Carapau D, Konert M, Hanson K, Carret C, Lassnig C, Müller M, Kalinke U, Saeed M, Chora A, Golenbock D, Strobl B, Prudêncio M, Coelho L, Kappe S, Superti-Furga G, Pichlmair A, Vigário A, Rice C, Fitzgerald K, Barchet W, Mota M
2014Journal of Immunology (baltimore, Md. : 1950)192 (5) : 2091-8
Cell contact-dependent priming and Fc interaction with CD32+ immune cells contribute to the TGN1412-triggered cytokine response
Bartholomaeus P, Semmler L, Bukur T, Boisguerin V, Römer P, Tabares P, Chuvpilo S, Tyrsin D, Matskevich A, Hengel H, Castle J, Hünig T, Kalinke U
2014Cancer Discovery4 (6) : 674-87
Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation
Bald T, Landsberg J, Lopez-Ramos D, Renn M, Glodde N, Jansen P, Gaffal E, Steitz J, Tolba R, Kalinke U, Limmer A, Jönsson G, Hölzel M, Tüting T